Be inspired by our keynote speakers.

Challenging what we think we know.

What if some of the assumptions we rely on no longer hold?
The opening and closing keynotes at SCDM EMEA 2026 will push you to challenge familiar narratives – about global stability, technological progress, and the role of data in healthcare. By encouraging us to question, reflect, and rethink, these sessions open the door to sharper judgment, better questions, and more informed decisions throughout in your daily work.
What if some of the assumptions we rely on no longer hold?
The opening and closing keynotes at SCDM EMEA 2026 will push you to challenge familiar narratives, about global stability, technological progress, and the role of data in healthcare. By encouraging us to question, reflect, and rethink, these sessions open the door to sharper judgment, better questions, and more informed decisions in your daily work.

Navigating a Fragmented World: Strategy, Resilience, and Europe’s Role in the New Global Order

Monday, 4 May 2026. From 9:15 to 10:30.

Jonathan Holslag is a Belgian political scientist and Professor of International Politics at the Vrije Universiteit Brussel, known for his sharp, realist analysis of global power shifts and for challenging comfortable narratives. His work connects geopolitics, trade, security, and history to the decisions societies make under pressure. By opening the SCDM 2026 EMEA Conference with this wider context, Jonathan sets the context for everything that follows, inviting us to think more critically about resilience, long‑term consequences, and the assumptions we bring into our work.

Controls, Care, and the Future of Therapy in the Age of Generative AI

Wednesday, 6 May 2026. From 11:45 to 13:15.

What happens when powerful technologies enter areas of care that lack the controls we rely on elsewhere in medicine? In this closing keynote, Dr Charlotte Blease - health informaticist and Associate Professor at Uppsala University, with research ties to Harvard Medical School - invites us to confront that question head‑on.
Focusing on psychotherapy and behavioural health, she explores how generative AI is becoming an active force in shaping patient beliefs, trust, and outcomes - amplifying placebo and nocebo effects at scale. For clinical data professionals, the implications are immediate: standards, oversight, accountability, and patient safety. Drawing on clinical data science principles, Charlotte opens the door to a more responsible, data‑driven, and human‑centred approach to AI in care, and leaves us with questions that stay with us well beyond the final session.